These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
36-3972986
|
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification Number)
|
|
Large accelerated filer
þ
|
Accelerated filer
¨
|
Non-accelerated filer
¨
|
Smaller reporting company
¨
|
|
|
|
|
Emerging growth company
¨
|
|
|
|
|
|
Page
|
|
|
|
|
|
|
PART I. FINANCIAL INFORMATION
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PART II. OTHER INFORMATION
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Unaudited)
|
|
|
||||
|
|
March 31,
2019 |
|
December 31,
2018 |
||||
|
ASSETS
|
|||||||
|
Current assets:
|
|
|
|
||||
|
Cash and cash equivalents
|
$
|
43.8
|
|
|
$
|
27.0
|
|
|
Receivables, less allowance for doubtful accounts of $9.9 in 2019 and 2018
|
241.3
|
|
|
311.6
|
|
||
|
Inventories
|
226.1
|
|
|
266.6
|
|
||
|
Other
|
108.0
|
|
|
116.0
|
|
||
|
Total current assets
|
619.2
|
|
|
721.2
|
|
||
|
Property, plant and equipment, net
|
1,048.2
|
|
|
1,052.0
|
|
||
|
Intangible assets, net
|
113.2
|
|
|
115.9
|
|
||
|
Goodwill
|
350.9
|
|
|
350.8
|
|
||
|
Investment in equity method investee
|
24.3
|
|
|
24.5
|
|
||
|
Other
|
152.8
|
|
|
103.5
|
|
||
|
Total assets
|
$
|
2,308.6
|
|
|
$
|
2,367.9
|
|
|
|
|
|
|
||||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|||||||
|
Current liabilities:
|
|
|
|
||||
|
Current portion of long-term debt
|
$
|
74.2
|
|
|
$
|
43.5
|
|
|
Accounts payable
|
90.5
|
|
|
111.3
|
|
||
|
Accrued salaries and wages
|
28.1
|
|
|
31.8
|
|
||
|
Income taxes payable
|
21.0
|
|
|
32.1
|
|
||
|
Accrued interest
|
7.5
|
|
|
9.7
|
|
||
|
Accrued expenses and other current liabilities
|
64.7
|
|
|
54.9
|
|
||
|
Total current liabilities
|
286.0
|
|
|
283.3
|
|
||
|
Long-term debt, net of current portion
|
1,225.6
|
|
|
1,321.2
|
|
||
|
Deferred income taxes, net
|
102.6
|
|
|
100.8
|
|
||
|
Other noncurrent liabilities
|
155.6
|
|
|
122.4
|
|
||
|
Commitments and contingencies (
Note 9
)
|
|
|
|
|
|
||
|
Stockholders’ equity:
|
|
|
|
||||
|
Common stock: $0.01 par value, 200,000,000 authorized shares; 35,367,264 issued shares
|
0.4
|
|
|
0.4
|
|
||
|
Additional paid-in capital
|
111.3
|
|
|
110.1
|
|
||
|
Treasury stock, at cost — 1,493,428 shares at March 31, 2019 and 1,513,808 shares at December 31, 2018
|
(3.1
|
)
|
|
(2.9
|
)
|
||
|
Retained earnings
|
626.4
|
|
|
643.5
|
|
||
|
Accumulated other comprehensive loss
|
(196.2
|
)
|
|
(210.9
|
)
|
||
|
Total stockholders’ equity
|
538.8
|
|
|
540.2
|
|
||
|
Total liabilities and stockholders’ equity
|
$
|
2,308.6
|
|
|
$
|
2,367.9
|
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Sales
|
$
|
403.7
|
|
|
$
|
437.9
|
|
|
Shipping and handling cost
|
112.9
|
|
|
120.1
|
|
||
|
Product cost
|
218.2
|
|
|
252.4
|
|
||
|
Gross profit
|
72.6
|
|
|
65.4
|
|
||
|
Selling, general and administrative expenses
|
39.4
|
|
|
38.8
|
|
||
|
Operating earnings
|
33.2
|
|
|
26.6
|
|
||
|
|
|
|
|
||||
|
Other expense (income):
|
|
|
|
||||
|
Interest expense
|
16.2
|
|
|
13.7
|
|
||
|
Net loss in equity investee
|
0.1
|
|
|
0.1
|
|
||
|
Other, net
|
4.4
|
|
|
(4.2
|
)
|
||
|
Earnings before income taxes
|
12.5
|
|
|
17.0
|
|
||
|
Income tax expense
|
4.9
|
|
|
4.4
|
|
||
|
Net earnings
|
$
|
7.6
|
|
|
$
|
12.6
|
|
|
|
|
|
|
||||
|
Basic net earnings per common share
|
$
|
0.22
|
|
|
$
|
0.37
|
|
|
Diluted net earnings per common share
|
$
|
0.22
|
|
|
$
|
0.37
|
|
|
|
|
|
|
||||
|
Weighted-average common shares outstanding (in thousands):
|
|
|
|
||||
|
Basic
|
33,874
|
|
|
33,836
|
|
||
|
Diluted
|
33,874
|
|
|
33,836
|
|
||
|
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Net earnings
|
$
|
7.6
|
|
|
$
|
12.6
|
|
|
Other comprehensive income (loss):
|
|
|
|
||||
|
Unrealized gain from change in pension obligations, net of tax of $(0.0) in both 2019 and 2018
|
0.1
|
|
|
0.1
|
|
||
|
Unrealized gain (loss) on cash flow hedges, net of tax of $(0.0) and $0.3 in 2019 and 2018, res
pectively
|
0.1
|
|
|
(0.5
|
)
|
||
|
Cumulative translation adjustment
|
14.5
|
|
|
(14.4
|
)
|
||
|
Comprehensive income (loss)
|
$
|
22.3
|
|
|
$
|
(2.2
|
)
|
|
|
Common
Stock
|
|
Additional
Paid-In
Capital
|
|
Treasury
Stock
|
|
Retained
Earnings
|
|
Accumulated
Other
Comprehensive
Loss
|
|
Total
|
||||||||||||
|
Balance, December 31, 2018
|
$
|
0.4
|
|
|
$
|
110.1
|
|
|
$
|
(2.9
|
)
|
|
$
|
643.5
|
|
|
$
|
(210.9
|
)
|
|
$
|
540.2
|
|
|
Comprehensive income
|
|
|
|
|
|
|
|
|
|
7.6
|
|
|
14.7
|
|
|
22.3
|
|
||||||
|
Cumulative effect of change in accounting principle
|
|
|
|
|
|
|
|
|
|
(0.1
|
)
|
|
|
|
|
(0.1
|
)
|
||||||
|
Dividends on common stock ($0.72 per share)
|
|
|
|
0.1
|
|
|
|
|
|
(24.6
|
)
|
|
|
|
|
(24.5
|
)
|
||||||
|
Shares issued for stock units, net of shares withheld for taxes
|
|
|
|
|
|
|
(0.2
|
)
|
|
|
|
|
|
|
|
(0.2
|
)
|
||||||
|
Stock-based compensation
|
|
|
|
1.1
|
|
|
|
|
|
|
|
|
|
|
|
1.1
|
|
||||||
|
Balance, March 31, 2019
|
$
|
0.4
|
|
|
$
|
111.3
|
|
|
$
|
(3.1
|
)
|
|
$
|
626.4
|
|
|
$
|
(196.2
|
)
|
|
$
|
538.8
|
|
|
|
Common
Stock
|
|
Additional
Paid-In
Capital
|
|
Treasury
Stock
|
|
Retained
Earnings
|
|
Accumulated
Other
Comprehensive
Loss
|
|
Total
|
||||||||||||
|
Balance, December 31, 2017
|
$
|
0.4
|
|
|
$
|
102.5
|
|
|
$
|
(2.9
|
)
|
|
$
|
672.5
|
|
|
$
|
(77.9
|
)
|
|
$
|
694.6
|
|
|
Comprehensive income (loss)
|
|
|
|
|
|
|
12.6
|
|
|
(14.8
|
)
|
|
(2.2
|
)
|
|||||||||
|
Stranded tax effect from tax reform
|
|
|
|
|
|
|
0.2
|
|
|
(0.2
|
)
|
|
—
|
|
|||||||||
|
Dividends on common stock ($0.72 per share)
|
|
|
0.1
|
|
|
|
|
(24.5
|
)
|
|
|
|
(24.4
|
)
|
|||||||||
|
Stock-based compensation
|
|
|
1.1
|
|
|
|
|
|
|
|
|
1.1
|
|
||||||||||
|
Balance, March 31, 2018
|
$
|
0.4
|
|
|
$
|
103.7
|
|
|
$
|
(2.9
|
)
|
|
$
|
660.8
|
|
|
$
|
(92.9
|
)
|
|
$
|
669.1
|
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Cash flows from operating activities:
|
|
|
|
||||
|
Net earnings
|
$
|
7.6
|
|
|
$
|
12.6
|
|
|
Adjustments to reconcile net earnings to net cash flows provided by operating activities:
|
|
|
|
||||
|
Depreciation, depletion and amortization
|
35.0
|
|
|
34.3
|
|
||
|
Finance fee amortization
|
0.7
|
|
|
0.6
|
|
||
|
Stock-based compensation
|
1.1
|
|
|
1.1
|
|
||
|
Deferred income taxes
|
(0.1
|
)
|
|
0.3
|
|
||
|
Net loss in equity method investee
|
0.1
|
|
|
0.1
|
|
||
|
Unrealized foreign exchange loss
|
0.2
|
|
|
0.2
|
|
||
|
Other, net
|
1.4
|
|
|
0.1
|
|
||
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
||
|
Receivables
|
72.0
|
|
|
68.9
|
|
||
|
Inventories
|
41.0
|
|
|
71.3
|
|
||
|
Other assets
|
17.3
|
|
|
0.5
|
|
||
|
Accounts payable and accrued expenses and other current liabilities
|
(46.7
|
)
|
|
(17.8
|
)
|
||
|
Other liabilities
|
(6.1
|
)
|
|
0.8
|
|
||
|
Net cash provided by operating activities
|
123.5
|
|
|
173.0
|
|
||
|
Cash flows from investing activities:
|
|
|
|
|
|
||
|
Capital expenditures
|
(21.5
|
)
|
|
(23.0
|
)
|
||
|
Other, net
|
(0.3
|
)
|
|
(0.6
|
)
|
||
|
Net cash used in investing activities
|
(21.8
|
)
|
|
(23.6
|
)
|
||
|
Cash flows from financing activities:
|
|
|
|
|
|
||
|
Proceeds from revolving credit facility borrowings
|
61.7
|
|
|
63.8
|
|
||
|
Principal payments on revolving credit facility borrowings
|
(139.6
|
)
|
|
(186.2
|
)
|
||
|
Proceeds from issuance of long-term debt
|
18.5
|
|
|
16.0
|
|
||
|
Principal payments on long-term debt
|
(5.5
|
)
|
|
(5.6
|
)
|
||
|
Dividends paid
|
(24.6
|
)
|
|
(24.5
|
)
|
||
|
Deferred financing costs
|
—
|
|
|
(0.3
|
)
|
||
|
Shares withheld to satisfy employee tax obligations
|
(0.2
|
)
|
|
—
|
|
||
|
Other, net
|
(0.3
|
)
|
|
—
|
|
||
|
Net cash used in financing activities
|
(90.0
|
)
|
|
(136.8
|
)
|
||
|
Effect of exchange rate changes on cash and cash equivalents
|
5.1
|
|
|
(4.7
|
)
|
||
|
Net change in cash and cash equivalents
|
16.8
|
|
|
7.9
|
|
||
|
Cash and cash equivalents, beginning of the year
|
27.0
|
|
|
36.6
|
|
||
|
Cash and cash equivalents, end of period
|
$
|
43.8
|
|
|
$
|
44.5
|
|
|
Supplemental cash flow information:
|
|
|
|
|
|
||
|
Interest paid, net of amounts capitalized
|
$
|
17.3
|
|
|
$
|
14.7
|
|
|
Income taxes paid, net of refunds
|
$
|
10.2
|
|
|
$
|
5.0
|
|
|
1.
|
Accounting Policies and Basis of Presentation:
|
|
|
|
3.
|
Leases:
|
|
|
Consolidated Balance Sheets Location
|
Three Months Ended
March 31, 2019 |
||
|
Assets
|
|
|
||
|
Operating lease assets
|
Other assets
|
$
|
47.2
|
|
|
Finance lease assets
|
Property, plant and equipment, net
|
6.6
|
|
|
|
Total leased assets
|
|
$
|
53.8
|
|
|
Liabilities
|
|
|
||
|
Current liabilities:
|
|
|
||
|
Operating
|
Accrued expenses and other current liabilities
|
$
|
16.7
|
|
|
Finance
|
Accrued expenses and other current liabilities
|
1.4
|
|
|
|
Noncurrent liabilities:
|
|
|
||
|
Operating
|
Other noncurrent liabilities
|
30.9
|
|
|
|
Finance
|
Other noncurrent liabilities
|
7.0
|
|
|
|
Total lease liabilities
|
|
$
|
56.0
|
|
|
|
Three Months Ended
March 31, 2019 |
||
|
Finance lease cost:
|
|
||
|
Amortization of lease assets
|
$
|
0.3
|
|
|
Interest on lease liabilities
|
0.2
|
|
|
|
Operating lease cost
|
4.8
|
|
|
|
Variable lease cost
(a)
|
6.1
|
|
|
|
Net lease cost
|
$
|
11.4
|
|
|
(a)
|
Short-term leases are immaterial and included in variable lease cost.
|
|
Topic 842
|
||||||||||
|
March 31, 2019
|
Operating Leases
|
Finance Leases
|
Total
|
|||||||
|
2019
|
$
|
14.4
|
|
$
|
1.4
|
|
$
|
15.8
|
|
|
|
2020
|
12.4
|
|
1.6
|
|
14.0
|
|
||||
|
2021
|
7.0
|
|
1.3
|
|
8.3
|
|
||||
|
2022
|
4.5
|
|
1.1
|
|
5.6
|
|
||||
|
2023
|
3.7
|
|
1.1
|
|
4.8
|
|
||||
|
After 2023
|
14.0
|
|
4.5
|
|
18.5
|
|
||||
|
Total lease payments
|
56.0
|
|
11.0
|
|
67.0
|
|
||||
|
Less: Interest
|
(8.4
|
)
|
(2.6
|
)
|
(11.0
|
)
|
||||
|
Present value of lease liabilities
|
$
|
47.6
|
|
$
|
8.4
|
|
$
|
56.0
|
|
|
|
Topic 840
|
||||||||||
|
December 31, 2018
|
Operating Leases
|
Finance Leases
|
Total
|
|||||||
|
2019
|
$
|
16.4
|
|
$
|
2.3
|
|
$
|
18.7
|
|
|
|
2020
|
10.6
|
|
1.8
|
|
12.4
|
|
||||
|
2021
|
5.7
|
|
1.3
|
|
7.0
|
|
||||
|
2022
|
4.4
|
|
1.1
|
|
5.5
|
|
||||
|
2023
|
3.6
|
|
1.1
|
|
4.7
|
|
||||
|
After 2023
|
14.3
|
|
4.6
|
|
18.9
|
|
||||
|
Total lease payments
|
$
|
55.0
|
|
$
|
12.2
|
|
$
|
67.2
|
|
|
|
|
Three Months Ended
March 31, 2019 |
|
|
Weighted-average remaining lease term (years)
|
|
|
|
Operating leases
|
6.0
|
|
|
Finance leases
|
7.6
|
|
|
Weighted-average discount rate
|
|
|
|
Operating leases
|
4.7
|
%
|
|
Finance leases
|
7.6
|
%
|
|
|
Three Months Ended
March 31, 2019 |
||
|
Cash paid for amounts included in the measurement of lease liabilities
|
|
||
|
Operating cash flows from operating leases
|
$
|
4.9
|
|
|
Operating cash flows from finance leases
|
$
|
0.2
|
|
|
Financing cash flows from finance leases
|
$
|
0.3
|
|
|
Leased assets obtained in exchange for new operating lease liabilities
|
$
|
2.4
|
|
|
Leased assets obtained in exchange for new finance lease liabilities
|
$
|
—
|
|
|
4.
|
Inventories:
|
|
|
March 31,
2019 |
|
December 31,
2018 |
||||
|
Finished goods
|
$
|
159.1
|
|
|
$
|
202.2
|
|
|
Raw materials and supplies
|
67.0
|
|
|
64.4
|
|
||
|
Total inventories
|
$
|
226.1
|
|
|
$
|
266.6
|
|
|
5.
|
Property, Plant and Equipment, Net:
|
|
|
March 31,
2019 |
|
December 31,
2018 |
||||
|
Land, buildings and structures, and leasehold improvements
|
$
|
587.5
|
|
|
$
|
580.7
|
|
|
Machinery and equipment
|
996.4
|
|
|
983.2
|
|
||
|
Office furniture and equipment
|
56.5
|
|
|
54.4
|
|
||
|
Mineral interests
|
169.4
|
|
|
168.1
|
|
||
|
Construction in progress
|
123.3
|
|
|
118.3
|
|
||
|
|
1,933.1
|
|
|
1,904.7
|
|
||
|
Less accumulated depreciation and depletion
|
(884.9
|
)
|
|
(852.7
|
)
|
||
|
Property, plant and equipment, net
|
$
|
1,048.2
|
|
|
$
|
1,052.0
|
|
|
6.
|
Goodwill and Intangible Assets, Net:
|
|
|
|
Three Months Ended
March 31, |
||||||
|
|
|
2019
|
|
2018
|
||||
|
Aggregate amortization expense
|
|
$
|
3.6
|
|
|
$
|
4.1
|
|
|
|
March 31,
2019 |
|
December 31,
2018 |
||||
|
Goodwill - Plant Nutrition North America Segment
|
$
|
53.8
|
|
|
$
|
52.6
|
|
|
Goodwill - Plant Nutrition South America Segment
|
291.2
|
|
|
292.3
|
|
||
|
Other
|
5.9
|
|
|
5.9
|
|
||
|
Total
|
$
|
350.9
|
|
|
$
|
350.8
|
|
|
7.
|
Income Taxes:
|
|
8.
|
Long-term Debt:
|
|
|
March 31,
2019 |
|
December 31,
2018 |
||||
|
Term Loans due July 2021
|
$
|
826.8
|
|
|
$
|
828.9
|
|
|
Revolving Credit Facility due July 2021
|
119.1
|
|
|
197.0
|
|
||
|
4.875% Senior Notes due July 2024
|
250.0
|
|
|
250.0
|
|
||
|
Banco Rabobank Loan due November 2019
|
18.0
|
|
|
18.1
|
|
||
|
Banco Itaú Loans due May 2019 to April 2020
|
0.5
|
|
|
0.8
|
|
||
|
Financiadora de Estudos e Projetos Loan due November 2023
|
8.8
|
|
|
9.3
|
|
||
|
Banco Santander Loan due September 2019
|
7.7
|
|
|
—
|
|
||
|
Banco Itaú Loan due March 2019
|
—
|
|
|
2.5
|
|
||
|
Banco Scotiabank Loan due September 2019
|
10.3
|
|
|
10.3
|
|
||
|
3.7% Banco Itaú loan due March 2020
|
15.4
|
|
|
15.4
|
|
||
|
Banco Santander loan due September 2020
|
20.6
|
|
|
20.6
|
|
||
|
Banco Santander loan due October 2020
|
16.7
|
|
|
16.8
|
|
||
|
Banco Santander loan due July 2019
|
10.3
|
|
|
—
|
|
||
|
Other
|
1.7
|
|
|
1.7
|
|
||
|
|
1,305.9
|
|
|
1,371.4
|
|
||
|
Less unamortized debt issuance costs
|
(6.1
|
)
|
|
(6.7
|
)
|
||
|
Total debt
|
1,299.8
|
|
|
1,364.7
|
|
||
|
Less current portion
|
(74.2
|
)
|
|
(43.5
|
)
|
||
|
Long-term debt
|
$
|
1,225.6
|
|
|
$
|
1,321.2
|
|
|
9.
|
Commitments and Contingencies:
|
|
10.
|
Operating Segments:
|
|
Three Months Ended March 31, 2019
|
|
Salt
|
|
Plant
Nutrition North America |
|
Plant
Nutrition South America |
|
Corporate
& Other (a) |
|
Total
|
||||||||||
|
Sales to external customers
|
|
$
|
306.4
|
|
|
$
|
37.2
|
|
|
$
|
57.7
|
|
|
$
|
2.4
|
|
|
$
|
403.7
|
|
|
Intersegment sales
|
|
—
|
|
|
0.5
|
|
|
1.5
|
|
|
(2.0
|
)
|
|
—
|
|
|||||
|
Shipping and handling cost
|
|
103.7
|
|
|
6.0
|
|
|
3.2
|
|
|
—
|
|
|
112.9
|
|
|||||
|
Operating earnings (loss)
|
|
52.3
|
|
|
(1.6
|
)
|
|
(2.6
|
)
|
|
(14.9
|
)
|
|
33.2
|
|
|||||
|
Depreciation, depletion and amortization
|
|
15.3
|
|
|
11.6
|
|
|
5.6
|
|
|
2.5
|
|
|
35.0
|
|
|||||
|
Total assets (as of end of period)
|
|
889.7
|
|
|
594.1
|
|
|
710.6
|
|
|
114.2
|
|
|
2,308.6
|
|
|||||
|
Three Months Ended March 31, 2018
|
|
Salt
|
|
Plant
Nutrition North America |
|
Plant
Nutrition South America |
|
Corporate
& Other (a) |
|
Total
|
||||||||||
|
Sales to external customers
|
|
$
|
315.9
|
|
|
$
|
52.9
|
|
|
$
|
66.3
|
|
|
$
|
2.8
|
|
|
$
|
437.9
|
|
|
Intersegment sales
|
|
—
|
|
|
0.2
|
|
|
0.4
|
|
|
(0.6
|
)
|
|
—
|
|
|||||
|
Shipping and handling cost
|
|
109.5
|
|
|
6.4
|
|
|
4.2
|
|
|
—
|
|
|
120.1
|
|
|||||
|
Operating earnings (loss)
|
|
34.1
|
|
|
4.9
|
|
|
0.8
|
|
|
(13.2
|
)
|
|
26.6
|
|
|||||
|
Depreciation, depletion and amortization
|
|
14.7
|
|
|
11.3
|
|
|
5.9
|
|
|
2.4
|
|
|
34.3
|
|
|||||
|
Total assets (as of end of period)
|
|
885.7
|
|
|
580.0
|
|
|
816.8
|
|
|
130.3
|
|
|
2,412.8
|
|
|||||
|
Three Months Ended March 31, 2019
|
|
Salt
|
|
Plant
Nutrition North America |
|
Plant
Nutrition South America |
|
Corporate
& Other (a) |
|
Total
|
||||||||||
|
Highway Deicing Salt
|
|
$
|
218.7
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
218.7
|
|
|
Consumer & Industrial Salt
|
|
87.7
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
87.7
|
|
|||||
|
SOP and Specialty Plant Nutrients
|
|
—
|
|
|
37.7
|
|
|
36.6
|
|
|
—
|
|
|
74.3
|
|
|||||
|
Industrial Chemicals
|
|
—
|
|
|
—
|
|
|
22.6
|
|
|
—
|
|
|
22.6
|
|
|||||
|
Eliminations & Other
|
|
—
|
|
|
(0.5
|
)
|
|
(1.5
|
)
|
|
2.4
|
|
|
0.4
|
|
|||||
|
Sales to external customers
|
|
$
|
306.4
|
|
|
$
|
37.2
|
|
|
$
|
57.7
|
|
|
$
|
2.4
|
|
|
$
|
403.7
|
|
|
Three Months Ended March 31, 2018
|
|
Salt
|
|
Plant
Nutrition North America
|
|
Plant
Nutrition South America |
|
Corporate
& Other
(a)
|
|
Total
|
||||||||||
|
Highway Deicing Salt
|
|
$
|
235.4
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
235.4
|
|
|
Consumer & Industrial Salt
|
|
80.5
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
80.5
|
|
|||||
|
SOP and Specialty Plant Nutrients
|
|
—
|
|
|
53.1
|
|
|
39.9
|
|
|
—
|
|
|
93.0
|
|
|||||
|
Industrial Chemicals
|
|
—
|
|
|
—
|
|
|
26.8
|
|
|
—
|
|
|
26.8
|
|
|||||
|
Eliminations & Other
|
|
—
|
|
|
(0.2
|
)
|
|
(0.4
|
)
|
|
2.8
|
|
|
2.2
|
|
|||||
|
Sales to external customers
|
|
$
|
315.9
|
|
|
$
|
52.9
|
|
|
$
|
66.3
|
|
|
$
|
2.8
|
|
|
$
|
437.9
|
|
|
(a)
|
Corporate and other includes corporate entities, records management operations and other incidental operations and eliminations. Operating earnings (loss) for corporate and other includes indirect corporate overhead, including costs for general corporate governance and oversight, as well as costs for the human resources, information technology, legal and finance functions.
|
|
Revenue
|
|
Three Months Ended
March 31, 2019 |
|
Three Months Ended
March 31, 2018 |
||||
|
United States
(a)
|
|
$
|
238.3
|
|
|
$
|
242.2
|
|
|
Canada
|
|
87.4
|
|
|
90.8
|
|
||
|
Brazil
|
|
55.7
|
|
|
65.6
|
|
||
|
United Kingdom
|
|
17.3
|
|
|
36.7
|
|
||
|
Other
|
|
5.0
|
|
|
2.6
|
|
||
|
Total Revenue
|
|
$
|
403.7
|
|
|
$
|
437.9
|
|
|
(a)
|
United States sales exclude product sold to foreign customers at U.S. ports.
|
|
11.
|
Stockholders’ Equity and Equity Instruments:
|
|
|
|
Stock Options
|
|
RSUs
|
|
PSUs
(a)
|
|||||||||||||||
|
|
|
Number
|
|
Weighted-average
exercise price
|
|
Number
|
|
Weighted-average
fair value
|
|
Number
|
|
Weighted-average
fair value
|
|||||||||
|
Outstanding at December 31, 2018
|
|
708,746
|
|
|
$
|
70.76
|
|
|
83,308
|
|
|
$
|
65.75
|
|
|
126,638
|
|
|
$
|
69.06
|
|
|
Granted
|
|
—
|
|
|
—
|
|
|
64,350
|
|
|
41.90
|
|
|
—
|
|
|
—
|
|
|||
|
Exercised
(b)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
Released from restriction
(b)
|
|
—
|
|
|
—
|
|
|
(22,358
|
)
|
|
65.33
|
|
|
—
|
|
|
—
|
|
|||
|
Cancelled/expired
|
|
(51,230
|
)
|
|
74.46
|
|
|
(1,281
|
)
|
|
64.98
|
|
|
(15,375
|
)
|
|
70.31
|
|
|||
|
Outstanding at March 31, 2019
|
|
657,516
|
|
|
$
|
70.47
|
|
|
124,019
|
|
|
$
|
53.46
|
|
|
111,263
|
|
|
$
|
68.89
|
|
|
(a)
|
Until they vest, PSUs are included in the table at the target level at their grant date and at that level represent
one
share of common stock per PSU.
|
|
(b)
|
Common stock issued for exercised options and for vested and earned RSUs and PSUs was issued from treasury stock.
|
|
Three Months Ended March 31, 2019
(a)
|
Gains and
(Losses) on
Cash Flow
Hedges
|
|
Defined
Benefit
Pension
|
|
Foreign
Currency
|
|
Total
|
||||||||
|
Beginning balance
|
$
|
(0.7
|
)
|
|
$
|
(4.5
|
)
|
|
$
|
(205.7
|
)
|
|
$
|
(210.9
|
)
|
|
Other comprehensive income before reclassifications
(b)
|
0.2
|
|
|
—
|
|
|
14.5
|
|
|
14.7
|
|
||||
|
Amounts reclassified from accumulated other comprehensive loss
|
(0.1
|
)
|
|
0.1
|
|
|
—
|
|
|
—
|
|
||||
|
Net current period other comprehensive income
|
0.1
|
|
|
0.1
|
|
|
14.5
|
|
|
14.7
|
|
||||
|
Ending balance
|
$
|
(0.6
|
)
|
|
$
|
(4.4
|
)
|
|
$
|
(191.2
|
)
|
|
$
|
(196.2
|
)
|
|
Three Months Ended March 31, 2018
(a)
|
Gains and
(Losses) on
Cash Flow
Hedges
|
|
Defined
Benefit
Pension
|
|
Foreign
Currency
|
|
Total
|
||||||||
|
Beginning balance
|
$
|
(0.9
|
)
|
|
$
|
(3.9
|
)
|
|
$
|
(73.1
|
)
|
|
$
|
(77.9
|
)
|
|
Other comprehensive loss before reclassifications
(b)
|
(0.2
|
)
|
|
—
|
|
|
(14.4
|
)
|
|
(14.6
|
)
|
||||
|
Amounts reclassified from accumulated other comprehensive loss
|
(0.3
|
)
|
|
0.1
|
|
|
—
|
|
|
(0.2
|
)
|
||||
|
Net current period other comprehensive (loss) income
|
(0.5
|
)
|
|
0.1
|
|
|
(14.4
|
)
|
|
(14.8
|
)
|
||||
|
Reclassification of stranded tax out of AOCL to retained earnings
(c)
|
(0.2
|
)
|
|
—
|
|
|
—
|
|
|
(0.2
|
)
|
||||
|
Ending balance
|
$
|
(1.6
|
)
|
|
$
|
(3.8
|
)
|
|
$
|
(87.5
|
)
|
|
$
|
(92.9
|
)
|
|
(a)
|
With the exception of the cumulative foreign currency translation adjustment, for which no tax effect is recorded, the changes in the components of accumulated other comprehensive income (loss) presented in the tables above are reflected net of applicable income taxes.
|
|
(b)
|
The Company recorded foreign exchange gains (losses) of
$2.3 million
and
$(4.4) million
in the
three
months ended
March 31, 2019
and
2018
, respectively, in accumulated other comprehensive loss related to intercompany notes which were deemed to be of a long-term investment nature.
|
|
(c)
|
In the first quarter of 2018, the Company adopted guidance which allows entities to reclassify tax effects of the change in U.S. income tax rates from accumulated other comprehensive loss to retained earnings.
|
|
|
|
|
|
|
|
||||
|
|
Amount Reclassified from AOCL
|
|
|
||||||
|
|
Three Months Ended
March 31, 2019 |
|
Three Months Ended
March 31, 2018 |
|
Line Item Impacted in the
Consolidated Statements of Operations
|
||||
|
Gains and (losses) on cash flow hedges:
|
|
|
|
|
|
||||
|
Natural gas instruments
|
$
|
(0.1
|
)
|
|
$
|
—
|
|
|
Product cost
|
|
Foreign currency contracts
|
(0.1
|
)
|
|
(0.5
|
)
|
|
Interest expense
|
||
|
Income tax expense
|
0.1
|
|
|
0.2
|
|
|
|
||
|
Reclassifications, net of income taxes
|
(0.1
|
)
|
|
(0.3
|
)
|
|
|
||
|
Amortization of defined benefit pension:
|
|
|
|
|
|
|
|
||
|
Amortization of loss
|
$
|
0.1
|
|
|
$
|
0.1
|
|
|
Product cost
|
|
Income tax expense
|
—
|
|
|
—
|
|
|
|
||
|
Reclassifications, net of income taxes
|
0.1
|
|
|
0.1
|
|
|
|
||
|
Total reclassifications, net of income taxes
|
$
|
—
|
|
|
$
|
(0.2
|
)
|
|
|
|
12.
|
Derivative Financial Instruments:
|
|
|
|
Asset Derivatives
|
|
Liability Derivatives
|
||||||||
|
Derivatives designated as hedging instruments:
|
|
Consolidated Balance Sheets Location
|
|
March 31, 2019
|
|
Consolidated Balance Sheets Location
|
|
March 31, 2019
|
||||
|
Commodity contracts
|
|
Other current assets
|
|
$
|
—
|
|
|
Accrued expenses and other current liabilities
|
|
$
|
0.4
|
|
|
Commodity contracts
|
|
Other assets
|
|
—
|
|
|
Other noncurrent liabilities
|
|
0.1
|
|
||
|
Swap contracts
|
|
Other current assets
|
|
1.9
|
|
|
Accrued expenses and other current liabilities
|
|
—
|
|
||
|
Swap contracts
|
|
Other assets
|
|
2.6
|
|
|
Other noncurrent liabilities
|
|
—
|
|
||
|
Total derivatives designated as hedging instruments
(a) (b)
|
|
|
|
$
|
4.5
|
|
|
|
|
$
|
0.5
|
|
|
(a)
|
The Company has master netting agreements with its commodity hedge counterparties and accordingly has netted in its Consolidated Balance Sheets an immaterial amount receivable from both counterparties.
|
|
(b)
|
The Company has both commodity hedge and foreign currency swap agreements with
two
counterparties each. Amounts recorded as liabilities for the Company’s commodity contracts are payable to both counterparties, and amounts recorded as assets for the Company’s foreign currency swap agreements are receivable from both counterparties.
|
|
|
|
Asset Derivatives
|
|
Liability Derivatives
|
||||||||
|
Derivatives designated as hedging instruments:
|
|
Consolidated Balance Sheets Location
|
|
December 31, 2018
|
|
Consolidated Balance Sheets Location
|
|
December 31, 2018
|
||||
|
Commodity contracts
|
|
Other current assets
|
|
$
|
—
|
|
|
Accrued expenses and other current liabilities
|
|
$
|
0.6
|
|
|
Swap contracts
|
|
Other current assets
|
|
2.2
|
|
|
Accrued expenses and other current liabilities
|
|
—
|
|
||
|
Swap contracts
|
|
Other assets
|
|
2.3
|
|
|
Other noncurrent liabilities
|
|
—
|
|
||
|
Total derivatives designated as hedging instruments
(a)(b)
|
|
|
|
$
|
4.5
|
|
|
|
|
$
|
0.6
|
|
|
(a)
|
The Company has master netting agreements with its commodity hedge counterparties and accordingly has netted in its Consolidated Balance Sheets less than
$0.1 million
of its commodity contracts that are in a receivable position against its contracts in payable positions.
|
|
(b)
|
The Company has both commodity hedge and foreign currency swap agreements with
two
counterparties each. Amounts recorded as liabilities for the Company’s commodity contracts are payable to both counterparties, and amounts recorded as assets for the Company’s foreign currency swap agreements are receivable from both counterparties.
|
|
13.
|
Fair Value Measurements:
|
|
|
March 31,
2019 |
|
Level One
|
|
Level Two
|
|
Level Three
|
||||||||
|
Asset Class:
|
|
|
|
|
|
|
|
||||||||
|
Mutual fund investments in a non-qualified savings plan
(a)
|
$
|
1.9
|
|
|
$
|
1.9
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Derivatives – foreign currency contracts, net
|
4.5
|
|
|
—
|
|
|
4.5
|
|
|
—
|
|
||||
|
Total Assets
|
$
|
6.4
|
|
|
$
|
1.9
|
|
|
$
|
4.5
|
|
|
$
|
—
|
|
|
Liability Class:
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Liabilities related to non-qualified savings plan
|
$
|
(1.9
|
)
|
|
$
|
(1.9
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Derivatives – natural gas instruments, net
|
(0.5
|
)
|
|
—
|
|
|
(0.5
|
)
|
|
—
|
|
||||
|
Total Liabilities
|
$
|
(2.4
|
)
|
|
$
|
(1.9
|
)
|
|
$
|
(0.5
|
)
|
|
$
|
—
|
|
|
(a)
|
Includes mutual fund investments of approximately
25%
in common stock of large-cap U.S. companies,
15%
in common stock of small to mid-cap U.S. companies,
5%
in international companies,
15%
in bond funds,
15%
in short-term investments and
25%
in blended funds.
|
|
|
December 31,
2018 |
|
Level One
|
|
Level Two
|
|
Level Three
|
||||||||
|
Asset Class:
|
|
|
|
|
|
|
|
||||||||
|
Mutual fund investments in a non-qualified savings plan
(a)
|
$
|
1.8
|
|
|
$
|
1.8
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Derivatives – foreign currency contracts, net
|
4.5
|
|
|
—
|
|
|
4.5
|
|
|
—
|
|
||||
|
Total Assets
|
$
|
6.3
|
|
|
$
|
1.8
|
|
|
$
|
4.5
|
|
|
$
|
—
|
|
|
Liability Class:
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Liabilities related to non-qualified savings plan
|
$
|
(1.8
|
)
|
|
$
|
(1.8
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Derivatives – natural gas instruments, net
|
(0.6
|
)
|
|
—
|
|
|
(0.6
|
)
|
|
—
|
|
||||
|
Total Liabilities
|
$
|
(2.4
|
)
|
|
$
|
(1.8
|
)
|
|
$
|
(0.6
|
)
|
|
$
|
—
|
|
|
(a)
|
Includes mutual fund investments of approximately
25%
in the common stock of large-cap U.S. companies,
15%
in the common stock of small to mid-cap U.S. companies,
5%
in the common stock of international companies,
20%
in bond funds,
15%
in short-term investments and
20%
in blended funds.
|
|
14.
|
Earnings per Share:
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Numerator:
|
|
|
|
||||
|
Net earnings
|
$
|
7.6
|
|
|
$
|
12.6
|
|
|
Less: net earnings allocated to participating securities
(a)
|
(0.2
|
)
|
|
(0.1
|
)
|
||
|
Net earnings available to common shareholders
|
$
|
7.4
|
|
|
$
|
12.5
|
|
|
|
|
|
|
||||
|
Denominator (in thousands):
|
|
|
|
|
|
||
|
Weighted-average common shares outstanding, shares for basic earnings per share
|
33,874
|
|
|
33,836
|
|
||
|
Weighted-average awards outstanding
(b)
|
—
|
|
|
—
|
|
||
|
Shares for diluted earnings per share
|
33,874
|
|
|
33,836
|
|
||
|
Net earnings per common share, basic
|
$
|
0.22
|
|
|
$
|
0.37
|
|
|
Net earnings per common share, diluted
|
$
|
0.22
|
|
|
$
|
0.37
|
|
|
(a)
|
Weighted participating securities include RSUs and PSUs that receive non-forfeitable dividends and consist of
233,000
and
163,000
weighted participating securities for the
three
months ended
March 31, 2019
and 2018, respectively.
|
|
(b)
|
For the calculation of diluted earnings per share, the Company uses the more dilutive of either the treasury stock method or the two-class method to determine the weighted-average number of outstanding common shares. In addition, the Company had
788,000
and
618,000
weighted-average equity awards outstanding for the
three
months ended
March 31, 2019
and 2018, respectively.
|
|
•
|
The largest rock salt mine in the world in Goderich, Ontario, Canada;
|
|
•
|
The largest dedicated rock salt mine in the U.K. in Winsford, Cheshire;
|
|
•
|
A solar evaporation facility located in Ogden, Utah, which is both the largest SOP production site and the largest solar salt production site in the Western Hemisphere;
|
|
•
|
Several mechanical evaporation facilities producing consumer and industrial salt; and
|
|
•
|
Several facilities producing essential agricultural nutrients and specialty chemicals in Brazil.
|
|
•
|
Total sales
decreased
8%
, or
$34.2 million
, due to decreases in all three segments.
|
|
•
|
Operating earnings
increased
25%
, or
$6.6 million
, due to increases in our Salt segment, which was partially offset by declines in both of our plant nutrition businesses.
|
|
•
|
Earnings before interest, taxes, depreciation and amortization (“EBITDA”)* adjusted for items management believes are not indicative of our ongoing operating performance (“Adjusted EBITDA”)*
increased
12%
, or
$7.3 million
.
|
|
•
|
Diluted net earnings per share decreased
41%
, or
$0.15
.
|
|
•
|
Salt segment gross profit increased $18.0 million primarily due to higher average sales prices, which were partially offset by increased per-unit shipping and handling costs.
|
|
•
|
The gross profit of the plant nutrition business, on a combined basis, decreased $10.8 million. The Plant Nutrition North America segment gross profit decreased $5.8 million primarily due to lower sales volumes and higher per-unit shipping and handling costs. The Plant Nutrition South America segment gross profit decreased $5.0 million primarily due to the timing of planned maintenance and higher raw material input costs.
|
|
•
|
The increase in SG&A expense was primarily due to higher incentive compensation, corporate professional services and information technology licenses and services agreement costs, which were partially offset by lower Plant Nutrition South America segment costs resulting from a weaker Brazilian reais compared to the U.S. dollar.
|
|
•
|
The increase was primarily due to higher U.S. interest rates and an increase in borrowings under our revolving credit facility.
|
|
•
|
We realized foreign exchange losses of $5.0 million in the first quarter of 2019 compared to foreign exchange gains of $3.1 million in the prior-year period. Lower interest income also contributed to the decrease.
|
|
•
|
The increase in income tax expense was primarily due to an increase in the effective tax rate, which was offset by lower pretax income in the first quarter of 2019.
|
|
•
|
Our income tax provision in both periods differs from the U.S. statutory rate primarily due to U.S. statutory depletion, state income taxes, foreign income, mining and withholding taxes and interest expense recognition differences for tax and financial reporting purposes. The global intangible low-taxed income (“GILTI”) also affected the 2019 income tax provision.
|
|
•
|
Our effective tax rate
increased
from
26%
in the
first
quarter of
2018
to
39%
in the
first
quarter of
2019
primarily due to the impact of a discrete tax item, GILTI and increased mining tax due to higher production at our Goderich mine in 2019 as compared to 2018.
|
|
|
1Q 2019
|
|
1Q 2018
|
||||
|
Salt Sales (in millions)
|
$
|
306.4
|
|
|
$
|
315.9
|
|
|
Salt Operating Earnings (in millions)
|
$
|
52.3
|
|
|
$
|
34.1
|
|
|
Salt Sales Volumes (thousands of tons)
|
|
|
|
||||
|
Highway deicing
|
3,543
|
|
|
4,262
|
|
||
|
Consumer and industrial
|
551
|
|
|
502
|
|
||
|
Total tons sold
|
4,094
|
|
|
4,764
|
|
||
|
Average Salt Sales Price (per ton)
|
|
|
|
||||
|
Highway deicing
|
$
|
61.73
|
|
|
$
|
55.24
|
|
|
Consumer and industrial
|
$
|
159.23
|
|
|
$
|
160.26
|
|
|
Combined
|
$
|
74.84
|
|
|
$
|
66.32
|
|
|
•
|
Salt sales
decreased
3%
, or
$9.5 million
, primarily due to lower highway deicing volumes, which was partially offset by higher highway deicing average sales prices and higher consumer and industrial sales volumes.
|
|
•
|
Average sales prices
increased
13%
and contributed $22.4 million to sales due to higher highway deicing prices. Salt average sales prices were also impacted by product sales mix, as consumer and industrial products, which have a higher average sales price, were a higher proportion of total sales in the current period.
|
|
•
|
Highway deicing average sales prices increased 12% due to the realization of higher North American highway deicing contract prices for the 2018-2019 winter season. Consumer and industrial average sales prices decreased
1%
.
|
|
•
|
Salt sales volumes
decreased
14%
, or
670,000
tons, and unfavorably impacted sales by
$31.9 million
. Highway deicing sales volumes
decreased
17%
as a result of mild weather in the U.K. when compared to the significantly above average winter weather in the first quarter of 2018 and lower North American contract volumes due primarily to lower production volumes at our Goderich mine. Consumer and industrial sales volumes
increased
10%
due to higher sales of consumer deicing products.
|
|
•
|
Salt operating earnings
increased
53%
, or
$18.2 million
, due to higher highway deicing prices in the first quarter of 2019. The first quarter of 2018 was impacted by higher per-unit product costs and higher carryover inventory costs resulting
|
|
|
1Q 2019
|
|
1Q 2018
|
||||
|
Plant Nutrition North America Sales (in millions)
|
$
|
37.2
|
|
|
$
|
52.9
|
|
|
Plant Nutrition North America Operating (Loss) Earnings (in millions)
|
$
|
(1.6
|
)
|
|
$
|
4.9
|
|
|
Plant Nutrition North America Sales Volumes (thousands of tons)
|
57
|
|
|
87
|
|
||
|
Plant Nutrition North America Average Sales Price (per ton)
|
$
|
656
|
|
|
$
|
610
|
|
|
•
|
Plant Nutrition North America sales
decreased
30%
, or
$15.7 million
.
|
|
•
|
Plant Nutrition North America sales volumes
decreased
34%
, or
30,000
tons, which resulted in a
$18.3 million
decrease in sales. The decrease in sales volumes resulted primarily from reduced customer purchases attributable to wet and cold weather in the first quarter of 2019.
|
|
•
|
Plant Nutrition North America average sales prices
increased
8%
, providing a
$2.6 million
offset to the decline in sales volumes reflecting a stronger product mix of our micronutrient sales.
|
|
•
|
Plant Nutrition North America operating results decreased
$6.5 million
to an operating loss of
$1.6 million
due to lower sales volumes, higher logistics costs and a less favorable geographic mix. Per unit logistics costs increased primarily due to longer shipping distances as fewer tons were sold in our primary markets due to wet and cold weather.
|
|
|
1Q 2019
|
|
1Q 2018
|
||||
|
Plant Nutrition South America Sales (in millions)
|
$
|
57.7
|
|
|
$
|
66.3
|
|
|
Plant Nutrition South America Operating (Loss) Earnings (in millions)
|
$
|
(2.6
|
)
|
|
$
|
0.8
|
|
|
Plant Nutrition South America Sales Volumes (thousands of tons)
|
|
|
|
||||
|
Agricultural productivity
|
52
|
|
|
61
|
|
||
|
Chemical solutions
|
82
|
|
|
79
|
|
||
|
Total tons sold
|
134
|
|
|
140
|
|
||
|
Average Plant Nutrition South America Sales Price (per ton)
|
|
|
|
||||
|
Agricultural productivity
|
$
|
681
|
|
|
$
|
646
|
|
|
Chemical solutions
|
$
|
275
|
|
|
$
|
339
|
|
|
Combined
|
$
|
431
|
|
|
$
|
473
|
|
|
•
|
Plant Nutrition South America sales
decreased
13%
, or
$8.6 million
, which were impacted by a 16% unfavorable weighted average change in the Brazilian reais versus the U.S. dollar from the prior year.
|
|
•
|
Plant Nutrition South America sales volumes
decreased
4%
, or
6,000
tons, which accounted for
$5.0 million
of the decrease in Plant Nutrition South America sales. Agricultural productivity sales volumes
decreased
15%
primarily reflecting uncertainty among Brazilian growers regarding the global agriculture market. Chemical solutions sales volumes
increased
4%
due to higher demand for water treatment products.
|
|
•
|
A
9%
decrease
in Plant Nutrition South America average sales price resulted in
$3.6 million
of the Plant Nutrition South America’s sales decrease due to a weaker Brazilian reais versus the U.S. dollar. In addition, the decrease in average sales price was due to a
19%
decrease
in chemical solutions product prices as a result of shifts in product sales mix. The decrease was partially offset by a
5%
increase
in agriculture product sales prices, reflecting shifts in product sales mix and price increases to cover increased raw material input costs.
|
|
•
|
Plant Nutrition South America operating results
decreased
$3.4 million
to an operating loss of
$2.6 million
, due to lower sales, the timing of planned maintenance and increased raw materials costs.
|
|
•
|
Due to better than anticipated year-to-date sales volumes, we expect Salt sales volumes for 2019 to range from 10.5 million tons to 11.0 million tons.
|
|
•
|
A shortened spring fertilizer season in many U.S. agriculture markets has reduced our full-year sales volume outlook for our Plant Nutrition North America products. As a result, we expect Plant Nutrition North America sales volumes for 2019 to range from 340,000 tons to 380,000 tons.
|
|
•
|
While we have experienced some recent uncertainty in Brazil’s agriculture markets, Plant Nutrition South America sales volumes is expected to range from 800,000 tons to 900,000 tons for 2019.
|
|
THREE MONTHS ENDED MARCH 31, 2019
|
THREE MONTHS ENDED MARCH 31, 2018
|
|
Operating Activities:
|
|
|
» Net earnings were $7.6 million.
|
» Net earnings were $12.6 million.
|
|
» Non-cash depreciation and amortization expense was $35.0 million.
|
» Non-cash depreciation and amortization expense was $34.3 million.
|
|
» Working capital items were a source of operating cash flows of $77.5 million.
|
» Working capital items were a source of operating cash flows of $123.7 million.
|
|
Investing Activities
:
|
|
|
» Net cash flows used by investing activities included $21.5 million of capital expenditures.
|
» Net cash flows used by investing activities included $23.0 million of capital expenditures.
|
|
Financing Activities
:
|
|
|
» Net cash flows used by financing activities included the payment of dividends of $24.6 million.
» In addition, we had net payments on our debt of $64.9 million.
|
» Net cash flows used by financing activities included the payment of dividends of $24.5 million.
» In addition, we had net payments on our debt of $112.0 million.
|
|
|
Three Months Ended
March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
Net earnings
|
$
|
7.6
|
|
|
$
|
12.6
|
|
|
Interest expense
|
16.2
|
|
|
13.7
|
|
||
|
Income tax expense
|
4.9
|
|
|
4.4
|
|
||
|
Depreciation, depletion and amortization
|
35.0
|
|
|
34.3
|
|
||
|
EBITDA
|
63.7
|
|
|
65.0
|
|
||
|
Adjustments to EBITDA:
|
|
|
|
|
|
||
|
Other expense (income), net
|
4.4
|
|
|
(4.2
|
)
|
||
|
Adjusted EBITDA
|
$
|
68.1
|
|
|
$
|
60.8
|
|
|
|
|
Exhibit
No.
|
|
Exhibit Description
|
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
101*
|
|
The following financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, formatted in Extensive Business Reporting Language (XBRL): (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Operations, (iii) Consolidated Statements of Comprehensive Income (Loss), (iv) Consolidated Statements of Stockholders’ Equity, (v) Consolidated Statements of Cash Flows, and (vi) the Notes to the Consolidated Financial Statements.
|
|
* Filed herewith
|
||
|
** Furnished herewith
|
||
|
|
COMPASS MINERALS INTERNATIONAL, INC.
|
|
|
|
|
|
|
|
|
Date: May 1, 2019
|
By:
|
/s/ James D. Standen
|
|
|
|
|
James D. Standen
|
|
|
|
|
Chief Financial Officer
|
|
|
|
|
(Principal Financial and Accounting Officer)
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|